Adare Pharmaceuticals, Inc. (formerly Aptalis/Actavis) is a specialty pharmaceutical company that develops enhanced pharmaceuticals and biopharmaceuticals based on its proprietary drug delivery technologies. The company specializes in bioavailability enhancement of poorly soluble drugs, modified release, taste masking and orally disintegrating tablet technologies. Adare also works with many of the world’s pharmaceutical and biotechnology companies to develop enhanced forms of their existing products and their compounds in development. The company is dedicated to the continued development and commercialization of breakthrough products that better satisfy patients’ needs, focusing research efforts on enhanced efficacy, superior safety and convenient dosing. Adare operates research, development, and manufacturing facilities in the United States and Europe, where proprietary technology formulation and manufacturing processes are located. The company’s manufacturing processes and units are integrated with R&D Facility facilities, enabling the scale-up and manufacturing process with shared development teams at a single site.